FOSINOPRIL SODIUM Drug Patent Profile

Which patents cover Fosinopril Sodium, and what generic alternatives are available?

Fosinopril Sodium is a drug marketed by Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher Smith Labs, Watson Labs, Ani Pharms, Aurobindo Pharma, Avet Lifesciences, Mylan, Sandoz, and Sun Pharm Inds Ltd. and is included in twenty NDAs.

The generic ingredient in FOSINOPRIL SODIUM is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Fosinopril Sodium

A generic version of FOSINOPRIL SODIUM was approved as fosinopril sodium; hydrochlorothiazide by SANDOZ on September 28^th, 2005.

Summary for FOSINOPRIL SODIUM

US Patents:	0
Applicants:	16
NDAs:	20
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	111
Clinical Trials:	5
Patent Applications:	1,955
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for FOSINOPRIL SODIUM
DailyMed Link:	FOSINOPRIL SODIUM at DailyMed

See drug prices for FOSINOPRIL SODIUM

See drug sales revenues for FOSINOPRIL SODIUM

Recent Clinical Trials for FOSINOPRIL SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sichuan Provincial People's Hospital	Phase 4
Shanghai Changzheng Hospital	Phase 4
The First Affiliated Hospital of Zhengzhou University	Phase 4

See all FOSINOPRIL SODIUM clinical trials

Pharmacology for FOSINOPRIL SODIUM

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Medical Subject Heading (MeSH) Categories for FOSINOPRIL SODIUM

Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for FOSINOPRIL SODIUM

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for FOSINOPRIL SODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avet Lifesciences	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	079025-002	Sep 17, 2010		DISCN	No	No
Watson Labs	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076987-003	Dec 23, 2004		DISCN	No	No
Sun Pharm Inds Ltd	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	076739-002	Dec 17, 2004		DISCN	No	No
Mylan	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	077705-002	Aug 14, 2006		DISCN	No	No
Teva	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	076945-001	Jul 5, 2006		DISCN	No	No